派林生物

- 000403

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
派林生物(000403) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入37,464.96265,468.46189,026.53113,617.8243,564.07
营业收入37,464.96265,468.46189,026.53113,617.8243,564.07
二、营业总成本27,648.08181,572.84127,963.9477,212.1629,748.55
营业成本19,459.13135,039.8293,538.4656,585.2321,163.94
营业税金及附加417.022,206.591,546.01946.55453.88
销售费用3,197.0024,460.3718,868.5210,299.043,395.65
管理费用4,574.9819,265.4913,108.048,512.893,994.35
财务费用-1,012.70-4,916.99-3,694.63-2,495.48-1,345.73
研发费用1,012.645,517.554,597.543,363.932,086.46
资产减值损失----------
公允价值变动收益-235.70638.07-1,059.22-1,370.32-423.86
投资收益594.591,773.862,938.962,437.47864.58
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润10,986.7488,031.3063,875.2238,249.6914,911.40
加:营业外收入0.9963.9610.599.8710.79
减:营业外支出651.492,817.461,931.161,174.28827.22
其中:非流动资产处置损失----------
四、利润总额10,336.2385,277.8161,954.6537,085.2814,094.97
减:所得税费用1,442.2810,773.597,678.804,387.701,907.99
五、净利润8,893.9574,504.2254,275.8532,697.5812,186.98
归属于母公司所有者的净利润8,908.9274,532.0854,273.2932,698.4412,194.86
少数股东损益-14.97-27.862.55-0.86-7.89
六、每股收益
基本每股收益(元/股)0.12001.02000.74250.44740.1669
稀释每股收益(元/股)0.12001.02000.74250.44740.1669
七、其他综合收益-0.070.77-0.560.350.10
八、综合收益总额8,893.8874,504.9854,275.2832,697.9312,187.08
归属于母公司所有者的综合收益总额8,908.8574,532.8454,272.7332,698.7912,194.96
归属于少数股东的综合收益总额-14.97-27.862.55-0.86-7.89
下载全部历史数据到excel中 返回页顶